Schrodinger, Inc. (SDGR) stock

SDGRNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 12/3076% above fair value

$30.85−0.67 (-2.13%)

Close on Nov 12, 2026Market cap $2.31BP/E –Yield –

Schrodinger total assets

Total assets on the balance sheet at the end of each period.

Schrodinger's total assets was $611.94M at Sep 30, 2026. For fiscal 2025 it was $726.16M, down 11.8% from the year before. The highest annual figure on record is $823.23M in fiscal 2024.

Annual total assets

Period	Period end	Value	Change
FY2025	Dec 31, 2025	$726.16M	-11.8%
FY2024	Dec 31, 2024	$823.23M	+2.5%
FY2023	Dec 31, 2023	$802.96M	+16.6%
FY2022	Dec 31, 2022	$688.59M	-9.0%
FY2021	Dec 31, 2021	$756.49M	+1.4%
FY2020	Dec 31, 2020	$746.26M	+380.6%
FY2019	Dec 31, 2019	$155.27M	–

Quarterly total assets

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q3 FY2026	Sep 30, 2026	$611.94M	-6.4%
Q2 FY2026	Jun 30, 2026	$640.39M	-7.0%
Q1 FY2026	Mar 31, 2026	$634.19M	-14.6%
Q4 FY2025	Dec 31, 2025	$726.16M	-11.8%
Q3 FY2025	Sep 30, 2025	$653.66M	-2.3%
Q2 FY2025	Jun 30, 2025	$688.24M	-0.0%
Q1 FY2025	Mar 31, 2025	$743.03M	+0.7%
Q4 FY2024	Dec 31, 2024	$823.23M	+2.5%
Q3 FY2024	Sep 30, 2024	$669.30M	-15.7%
Q2 FY2024	Jun 30, 2024	$688.37M	-18.2%
Q1 FY2024	Mar 31, 2024	$737.76M	-12.0%
Q4 FY2023	Dec 31, 2023	$802.96M	+16.6%
Q3 FY2023	Sep 30, 2023	$794.15M	+20.0%
Q2 FY2023	Jun 30, 2023	$841.57M	+22.3%
Q1 FY2023	Mar 31, 2023	$838.77M	+16.6%
Q4 FY2022	Dec 31, 2022	$688.59M	-9.0%
Q3 FY2022	Sep 30, 2022	$661.99M	-13.2%
Q2 FY2022	Jun 30, 2022	$687.88M	-4.1%
Q1 FY2022	Mar 31, 2022	$719.54M	-3.3%
Q4 FY2021	Dec 31, 2021	$756.49M	+1.4%
Q3 FY2021	Sep 30, 2021	$762.62M	+12.1%
Q2 FY2021	Jun 30, 2021	$717.33M	+105.2%
Q1 FY2021	Mar 31, 2021	$744.19M	+112.7%
Q4 FY2020	Dec 31, 2020	$746.26M	+380.6%
Q3 FY2020	Sep 30, 2020	$680.12M	–
Q2 FY2020	Jun 30, 2020	$349.55M	–
Q1 FY2020	Mar 31, 2020	$349.87M	–
Q4 FY2019	Dec 31, 2019	$155.27M	–